Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
GOLDMAN SACHS GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX)
- Filing manager
- GOLDMAN SACHS GROUP INC
- Reporting owner
- THE GOLDMAN SACHS GROUP, INC.
- Beneficially owned shares
- 5,581,828 shares
- Class ownership
- 6.5%
- Large-stake signal
-
Ownership
6.5%
Beneficial ownership of this reported class.
Shares
5,581,828 shares
Shares beneficially owned as disclosed.
Event date
30 Jun 2025
Date tied to the ownership event or amendment.
Accepted by SEC
13 Aug 2025
EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Symbol
- SNDX
- Shares outstanding
- 85,874,278 shares
- Form type
- SCHEDULE 13G/A
- Accepted by SEC
- 13 Aug 2025, 17:52:51 UTC
- Event date
- 30 Jun 2025
- Previous filing
- 09 May 2025
- SEC filing
- View on sec.gov
Ownership signal
2 signals
Subject security
2 source fields
Source evidence
5 source fields
Key filing fact
GOLDMAN SACHS GROUP INC disclosed 6.5% ownership in SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX) on 30 Jun 2025.
Key facts
- GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for SYNDAX PHARMACEUTICALS, INC. Common Stock (SNDX).
- Disclosed ownership: 6.5%.
- Date of event: 30 Jun 2025.
Change
- Previous schedule filing date: 09 May 2025.
- Current filing was accepted on 13 Aug 2025, 17:52.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (2)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 6.5% | 5,581,828 | 0 | 5,581,718 | Name: | Attorney-in-fact | |
| GOLDMAN SACHS & CO. LLC | 6.5% | 5,581,828 | 0 | 5,581,718 | Name: | Attorney-in-fact |
CIK / CUSIP context first